Wordt geladen...
Clinical Experience with Argatroban for Heparin-Induced Thrombocytopenia in a Large Teaching Hospital
BACKGROUND: Argatroban is a direct thrombin inhibitor approved for the prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia (HIT). The product monograph does not guide clinicians beyond specifying the initial dose of 2 μg/kg per minute (or 0.5 μg/kg per minute for...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Canadian Society of Hospital Pharmacists
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2826966/ https://ncbi.nlm.nih.gov/pubmed/22478907 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|